Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 43,946 shares at $301.61 ($13.4M) on 2022-08-15, disclosed to the SEC on 2022-08-17.
Seasonal sale ($13.4M) by EVP, COO — this insider has traded VRTX in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.30 | 1,254 | $377K | 2.8% |
| 2 | $300.30 | 1,254 | $377K | 2.8% |
| 3 | $301.61 | 4,242 | $1.3M | 9.6% |
| 4 | $301.61 | 4,242 | $1.3M | 9.6% |
| 5 | $302.55 | 400 | $121K | 0.9% |
| 6 | $303.78 | 2,339 |
| $711K |
| 5.3% |
| 7 | $303.78 | 2,339 | $711K | 5.3% |
| 8 | $304.67 | 6,990 | $2.1M | 15.9% |
| 9 | $304.67 | 6,990 | $2.1M | 15.9% |
| 10 | $305.38 | 6,948 | $2.1M | 15.9% |
| 11 | $305.38 | 6,948 | $2.1M | 15.9% |
| Total | $303.94 avg | 43,946 | $13.4M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |